Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions

Official record

Identifier

NCT07737171

Recruiting locations

country

United States

Interventions studied

Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA)

Lead sponsor

The University of Texas Health Science Center, Houston

Target enrolment

60 participants

Study type

OBSERVATIONAL

Phase

Not provided in the official record

Status

Recruiting

First posted

Jul 30, 2026

Last updated on the registry

Jul 30, 2026

Age

18 Years

Sex

ALL

Study contact

The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* Diagnosis of any pancreatic pre-malignant lesion and/or pancreatic malignancy
* Patients already undergoing EUS-RFA for treatment of pancreatic lesions clinically

Exclusion Criteria:

* Patients with co-existing malignancies of other organs (or a prior history of such)
* Patients unable to provide informed consent
* Patients unable to complete follow-up

Indexed under

Pancreatic Cancer